Financhill
Back

EyePoint Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EyePoint Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.74 Buy
20-day SMA: 13.35 Buy
50-day SMA: 12.97 Buy
200-day SMA: 9.68 Buy
8-day EMA: 14.74 Buy
20-day EMA: 13.84 Buy
50-day EMA: 13.04 Buy
200-day EMA: 10.99 Buy

EyePoint Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.76 Buy
Relative Strength Index (14 RSI): 71.04 Buy
Chaikin Money Flow: 1591272 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.65 - 14.61) Buy
Bollinger Bands (100): (10.8 - 13.78) Buy

EyePoint Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for EyePoint Pharmaceuticals, Inc. Stock

Is EyePoint Pharmaceuticals, Inc. Stock a Buy?

EYPT Technical Analysis vs Fundamental Analysis

Buy
56
EyePoint Pharmaceuticals, Inc. (EYPT) is a Buy

Is EyePoint Pharmaceuticals, Inc. a Buy or a Sell?

EyePoint Pharmaceuticals, Inc. Stock Info

Market Cap:
1.4B
Price in USD:
16.72
Share Volume:
2M

EyePoint Pharmaceuticals, Inc. 52-Week Range

52-Week High:
17.00
52-Week Low:
3.91
Buy
56
EyePoint Pharmaceuticals, Inc. (EYPT) is a Buy

EyePoint Pharmaceuticals, Inc. Share Price Forecast

Is EyePoint Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of EyePoint Pharmaceuticals, Inc.

Is EyePoint Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.85 per share, and an increase next year of $0.25 per share.

Technical Analysis of EyePoint Pharmaceuticals, Inc.

Should I short EyePoint Pharmaceuticals, Inc. stock?

* EyePoint Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.